ActivOnline: Physical Activity in Cystic Fibrosis Trial UK (ActiOnPACTUK)
Primary Purpose
Cystic Fibrosis
Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
ActivOnline
Sponsored by
About this trial
This is an interventional treatment trial for Cystic Fibrosis
Eligibility Criteria
Inclusion Criteria:
- Confirmed diagnosis of CF
- Aged 12-35 years (inclusive)
- Able to provide informed consent/assent
- Able to access the internet via computer or mobile device
Exclusion Criteria:
- Presence of severe co-morbidity limiting mobilisation or physical activity participation (e.g. orthopaedic, cardiac or neurological condition)
- Previous lung transplantation
- Pregnancy
- Unable to provide informed consent/assent
Sites / Locations
- University of ExeterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention
Control
Arm Description
Access to online physical activity platform (www.activonline.com.au) in addition to usual care.
No access to online physical activity platform. Continue with usual care.
Outcomes
Primary Outcome Measures
Change in physical activity, objectively measures using ActiGrpah GT9X Link accelerometer.
Time spent in sedentary, light, moderate and vigorous physical activity domains will be assessed over a one week period. Accelerometer to be worn on non-dominant wrist.
Change in physical activity, subjectively measured using the Habitual Activity Estimation Scale.
Questionnaire determines time spent being inactive, somewhat inactive, somewhat active and very active, each reported as a percentage of the day.
Secondary Outcome Measures
Change in forced expiratory volume in one second (FEV1), measured in absolute units (L)
Assessment of lung function
Change in forced vital capacity (FVC), measured in absolute units (L)
Assessment of lung function
Change in forced expiratory volume in one second (FEV1), measured as a percent of predicted, as per GLI2012 equations.
Assessment of lung function
Change in forced vital capacity (FVC), measured as a percent of predicted, as per GLI2012 equations.
Assessment of lung function
Change in exercise attitudes, measured using the Behavioural Regulation in Exercise Questionnaire.
Assessment of reasons underlying people's decision to engage, or not engage, in exercise. Scores range from -24 to +20, where a higher score indicates greater exercise autonomy (better outcome).
Change in quality of life, measured using age-specific Cystic Fibrosis Questionnaire (Revised).
Subjective assessment of health related quality of life, scored from 0 to 100 where a higher score indicates higher quality of life (better outcome).
Change in anxiety, measured using Hospital Anxiety and Depression Scale.
Subjective report of anxiety, scored from 0 to 21, where a higher score indicates higher anxiety (worse outcome).
Change in depression, measured using Hospital Anxiety and Depression Scale.
Subjective report of depression, scored from 0 to 21, where a higher score indicates higher depression (worse outcome).
Change in depression, measured using Center for Epidemiological Studies-Depression Scale.
Subjective reports of anxiety and depression, scored from 0 to 60 where a higher score indicates greater depressive symptoms (worse outcome).
Change in sleep quality, measured using Pittsburgh Sleep Quality Index (PSQI).
Subjective report of sleep quality, scored from 0 to 21 where a higher score indicates worse sleep quality (worse outcome).
Full Information
NCT ID
NCT04249999
First Posted
November 13, 2019
Last Updated
July 9, 2021
Sponsor
University of Exeter
Collaborators
Cystic Fibrosis Trust, Sport England, Monash University
1. Study Identification
Unique Protocol Identification Number
NCT04249999
Brief Title
ActivOnline: Physical Activity in Cystic Fibrosis Trial UK
Acronym
ActiOnPACTUK
Official Title
A Randomised Controlled Trial of a Novel Web-based Intervention to Promote Physical Activity Participation in People With Cystic Fibrosis
Study Type
Interventional
2. Study Status
Record Verification Date
July 2021
Overall Recruitment Status
Unknown status
Study Start Date
May 7, 2020 (Actual)
Primary Completion Date
March 2022 (Anticipated)
Study Completion Date
July 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Exeter
Collaborators
Cystic Fibrosis Trust, Sport England, Monash University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Increased level of physical activity (PA) are of benefit in the management of cystic fibrosis (CF). This randomised control tial will assess whether three-months use of an online platform can help increase PA levels in people with CF (compared to a control group continuing routine treatment).
Detailed Description
Cystic fibrosis (CF) is a genetic condition that predominantly affects the lungs through an accumulation of thick mucus. As there is no cure for CF, it is a disease that is managed through intensive medication, nutrition, physiotherapy, exercise and physical activity (PA).
Increased levels of PA are of benefit to people with CF, and therefore interventions that promote PA are warranted, particularly in adolescence, whereby PA levels decrease. Telehealth interventions are of particular interest in CF, whereby strict cross-infection guidelines prevent patients meeting in person, and allowing patients to overcome geographical barriers at the same time.
Previous research has shown engagement with an online platform (www.activonline.com.au), specifically designed to monitor PA in CF, is feasible and acceptable to people with CF. Therefore, a full randomised control trial is warranted to assess the efficacy of this intervention in changing PA.
UPDATE JUNE 2021: Due to ongoing restrictions placed upon research by the global COVID-19 pandemic, modifications to the protocol are necessary.
Recruitment and consenting will now take place online, and testing procedures will be completed by participants in their own homes. The nature, and length of, intervention remains unchanged.
Changes to protocol approved by ethics board on May 4th 2021.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Masking Description
Physical activity intervention. Assignment to intervention or control group cannot be blinded.
Follow-up assessments will be conducted by blinded assessors.
UPADTE JUNE 2021: As noted in update above, all participants will perform procedures themselves within their own homes (i.e. physical activity, lung function, questionnaires). Therefore, use of blinded assessors is no longer applicable.
Allocation
Randomized
Enrollment
94 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Access to online physical activity platform (www.activonline.com.au) in addition to usual care.
Arm Title
Control
Arm Type
No Intervention
Arm Description
No access to online physical activity platform. Continue with usual care.
Intervention Type
Behavioral
Intervention Name(s)
ActivOnline
Intervention Description
Access to online physical activity platform (www.activonline.com.au)
Primary Outcome Measure Information:
Title
Change in physical activity, objectively measures using ActiGrpah GT9X Link accelerometer.
Description
Time spent in sedentary, light, moderate and vigorous physical activity domains will be assessed over a one week period. Accelerometer to be worn on non-dominant wrist.
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Title
Change in physical activity, subjectively measured using the Habitual Activity Estimation Scale.
Description
Questionnaire determines time spent being inactive, somewhat inactive, somewhat active and very active, each reported as a percentage of the day.
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Secondary Outcome Measure Information:
Title
Change in forced expiratory volume in one second (FEV1), measured in absolute units (L)
Description
Assessment of lung function
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Title
Change in forced vital capacity (FVC), measured in absolute units (L)
Description
Assessment of lung function
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Title
Change in forced expiratory volume in one second (FEV1), measured as a percent of predicted, as per GLI2012 equations.
Description
Assessment of lung function
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Title
Change in forced vital capacity (FVC), measured as a percent of predicted, as per GLI2012 equations.
Description
Assessment of lung function
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Title
Change in exercise attitudes, measured using the Behavioural Regulation in Exercise Questionnaire.
Description
Assessment of reasons underlying people's decision to engage, or not engage, in exercise. Scores range from -24 to +20, where a higher score indicates greater exercise autonomy (better outcome).
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Title
Change in quality of life, measured using age-specific Cystic Fibrosis Questionnaire (Revised).
Description
Subjective assessment of health related quality of life, scored from 0 to 100 where a higher score indicates higher quality of life (better outcome).
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Title
Change in anxiety, measured using Hospital Anxiety and Depression Scale.
Description
Subjective report of anxiety, scored from 0 to 21, where a higher score indicates higher anxiety (worse outcome).
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Title
Change in depression, measured using Hospital Anxiety and Depression Scale.
Description
Subjective report of depression, scored from 0 to 21, where a higher score indicates higher depression (worse outcome).
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Title
Change in depression, measured using Center for Epidemiological Studies-Depression Scale.
Description
Subjective reports of anxiety and depression, scored from 0 to 60 where a higher score indicates greater depressive symptoms (worse outcome).
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Title
Change in sleep quality, measured using Pittsburgh Sleep Quality Index (PSQI).
Description
Subjective report of sleep quality, scored from 0 to 21 where a higher score indicates worse sleep quality (worse outcome).
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks).
Other Pre-specified Outcome Measures:
Title
Qualitative assessment of barriers and facilitators to physical activity
Description
Semi-structured, 10-item interview for participants in both intervention and control group
Time Frame
3-months post-intervention (+24 weeks)
Title
Qualitative assessment of Activ Online programme
Description
Semi-structured interview question for participants assigned to intervention group
Time Frame
3-months post-intervention (+24 weeks)
Title
Usage of Activ Online programme
Description
Frequency of access and logging of physical activity data
Time Frame
Post-intervention (+12 weeks)
Title
Changes in physical activity, measured by Sport England Short Active Lives Survey.
Description
Subjective assessment of physical activity
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks)
Title
Changes in physical activity, measured by Sport England Engagement in Sport Questions
Description
Subjective assessment of physical activity
Time Frame
Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Confirmed diagnosis of CF
Aged 12-35 years (inclusive)
Able to provide informed consent/assent
Able to access the internet via computer or mobile device
Exclusion Criteria:
Presence of severe co-morbidity limiting mobilisation or physical activity participation (e.g. orthopaedic, cardiac or neurological condition)
Previous lung transplantation
Pregnancy
Unable to provide informed consent/assent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Owen W Tomlinson, PhD
Phone
+44(0)1392727049
Email
o.w.tomlinson@exeter.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Craig A Williams, PhD
Organizational Affiliation
University of Exeter
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Exeter
City
Exeter
State/Province
Devon
ZIP/Postal Code
EX1 2LU
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Owen W Tomlinson, PhD
Phone
+44(0)1392727049
Email
o.w.tomlinson@exeter.ac.uk
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
25425703
Citation
Cox NS, Alison JA, Button BM, Wilson JW, Holland AE. Feasibility and acceptability of an internet-based program to promote physical activity in adults with cystic fibrosis. Respir Care. 2015 Mar;60(3):422-9. doi: 10.4187/respcare.03165. Epub 2014 Nov 25.
Results Reference
background
PubMed Identifier
31856791
Citation
Cox NS, Eldridge B, Rawlings S, Dreger J, Corda J, Hauser J, Button BM, Bishop J, Nichols A, Middleton A, Ward N, Dwyer T, Tomlinson OW, Denford S, Barker AR, Williams CA, Kingsley M, O'Halloran P, Holland AE; Youth Activity Unlimited - A Strategic Research Centre of the UK Cystic Fibrosis Trust. A web-based intervention to promote physical activity in adolescents and young adults with cystic fibrosis: protocol for a randomized controlled trial. BMC Pulm Med. 2019 Dec 19;19(1):253. doi: 10.1186/s12890-019-0942-3.
Results Reference
background
Learn more about this trial
ActivOnline: Physical Activity in Cystic Fibrosis Trial UK
We'll reach out to this number within 24 hrs